Anthem Bioscienc

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
650.35
-11.15 (-1.69%)
BSENSE

Dec 05

BSE+NSE Vol: 6.39 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Net Sales
1,090.24
863.55
Other Operating Income
0.00
0.00
Total Operating income
1,090.24
863.55
Raw Material Cost
363.47
391.93
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
90.77
-57.57
Employee Cost
139.75
143.85
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
86.85
69.21
Total Expenditure (Excl Depreciation)
680.84
547.42
Operating Profit (PBDIT) excl Other Income
409.40
316.13
Other Income
71.04
47.30
Operating Profit (PBDIT)
480.44
363.43
Interest
4.64
7.26
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
475.80
356.17
Depreciation
59.95
38.67
Profit Before Tax
415.85
317.51
Tax
106.63
73.20
Provisions and contingencies
0.00
0.00
Profit After Tax
309.22
244.31
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
309.22
244.31
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
309.22
244.31
Equity Capital
112.32
112.32
Face Value
2.0
2.0
Reserves
0.00
0.00
Earnings per share (EPS)
5.51
4.35
Diluted Earnings per share
5.45
4.29
Operating Profit Margin (Excl OI)
37.55%
36.61%
Gross Profit Margin
43.64%
41.24%
PAT Margin
28.36%
28.29%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 26.27%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 35.65%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.95%

stock-summary

Interest

Growth in half year ended Sep 2025 is -26.15%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Anthem Bioscienc With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,090.24
1,785.11
-694.87
-38.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,090.24
1,785.11
-694.87
-38.93%
Raw Material Cost
363.47
243.19
120.28
49.46%
Purchase of Finished goods
0.00
464.78
-464.78
-100.00%
(Increase) / Decrease In Stocks
90.77
-64.73
155.50
240.23%
Employee Cost
139.75
290.62
-150.87
-51.91%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
86.85
264.32
-177.47
-67.14%
Total Expenditure (Excl Depreciation)
680.84
1,198.18
-517.34
-43.18%
Operating Profit (PBDIT) excl Other Income
409.40
586.93
-177.53
-30.25%
Other Income
71.04
77.29
-6.25
-8.09%
Operating Profit (PBDIT)
480.44
664.22
-183.78
-27.67%
Interest
4.64
0.93
3.71
398.92%
Exceptional Items
0.00
2.64
-2.64
-100.00%
Gross Profit (PBDT)
475.80
665.93
-190.13
-28.55%
Depreciation
59.95
32.95
27.00
81.94%
Profit Before Tax
415.85
632.98
-217.13
-34.30%
Tax
106.63
170.48
-63.85
-37.45%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
309.22
462.50
-153.28
-33.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
309.22
462.50
-153.28
-33.14%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
309.22
462.50
-153.28
-33.14%
Equity Capital
112.32
169.41
-57.09
-33.70%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.51
27.30
-21.79
-79.82%
Diluted Earnings per share
5.45
27.30
-21.85
-80.04%
Operating Profit Margin (Excl OI)
37.55%
32.88%
0.00
4.67%
Gross Profit Margin
43.64%
37.30%
0.00
6.34%
PAT Margin
28.36%
25.91%
0.00
2.45%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,090.24 Cr
in Sep 2025

Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 346.77 Cr
in Sep 2025

Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 421.08 Cr
in Sep 2025

Figures in Cr
Half Yearly - Interest
Interest 3.84 Cr
in Sep 2025

Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.62%
in Sep 2025

Figures in %